Close this search box.

Karuna vet Paul among new Third Rock venture partners

ARTICLE | Management Tracks

Plus: three new executives at Soleno and updates from Zentalis, Slingshot, Actio, Kronos, Osivax, Cellular Origins and ConcertAI

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst

January 26, 2024 12:30 AM UTC

Third Rock Ventures recruited Steve Paul, who recently stepped down as CSO and president of R&D of Karuna Therapeutics Inc. (NASDAQ:KRTX). Paul joins the VC as one of four new venture partners, alongside Vyas Ramanan, whom the VC promoted from principal, and new hires Mary Lynne Hedley and Courtney Wallace. Hedley co-founded Tesaro Inc., which was acquired by GSK plc (LSE:GSK; NYSE:GSK); Wallace was CBO at Beam Therapeutics Inc. (NASDAQ:BEAM). Third Rock also promoted Jigar Raythatha to partner from venture partner.

Rare disease company Soleno Therapeutics Inc. (NASDAQ:SLNO) hired Meredith Manning as chief commercial officer (CCO), Dairine Dempsey as VP, Europe, and Lauren Budesheim as VP of human resources. Manning was president of the Americas at PharmaEssentia Corp. (TPEx:6446). Dempsey has consulted for Soleno since 2019; and Budesheim was head of people at Neurona Therapeutics Inc…